Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MEDIFAST INC (MED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: MED (1-star) is a SELL. SELL since 3 days. Simulated Profits (-8.99%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $15
1 Year Target Price $15
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -39.98% | Avg. Invested days 20 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 144.75M USD | Price to earnings Ratio 39.91 | 1Y Target Price 15 |
Price to earnings Ratio 39.91 | 1Y Target Price 15 | ||
Volume (30-day avg) 1 | Beta 0.88 | 52 Weeks Range 11.57 - 21.98 | Updated Date 10/15/2025 |
52 Weeks Range 11.57 - 21.98 | Updated Date 10/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.33 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.76% | Operating Margin (TTM) -1.01% |
Management Effectiveness
Return on Assets (TTM) 2.88% | Return on Equity (TTM) 1.73% |
Valuation
Trailing PE 39.91 | Forward PE - | Enterprise Value 642844 | Price to Sales(TTM) 0.3 |
Enterprise Value 642844 | Price to Sales(TTM) 0.3 | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA 0.05 | Shares Outstanding 10991064 | Shares Floating 9146450 |
Shares Outstanding 10991064 | Shares Floating 9146450 | ||
Percent Insiders 3.2 | Percent Institutions 79.77 |
Upturn AI SWOT
MEDIFAST INC
Company Overview
History and Background
Medifast, Inc. was founded in 1980. It focuses on providing weight management and healthy living products and services through various channels.
Core Business Areas
- OPTAVIA: OPTAVIA is Medifast's direct-selling business segment, offering a comprehensive weight management program supported by independent health coaches.
Leadership and Structure
The CEO is Dan Chard. The company is structured around functional departments like sales, marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- OPTAVIA Program: OPTAVIA is a structured weight management program that includes meal replacements (Fuelings), personalized coaching, and a community support system. Market share data is not precisely available, but OPTAVIA is a significant player in the weight management market. Competitors include WW (WeightWatchers), Nutrisystem, and Herbalife.
- Fuelings: Fuelings are Medifast's brand name for meal replacements for the OPTAVIA Program, including bars, shakes, and other pre-packaged meals. Market share data is not precisely available, but OPTAVIA is a significant player in the meal replacement market. Competitors include Atkins, SlimFast, and Ensure.
Market Dynamics
Industry Overview
The weight management industry is competitive, with various diet programs, meal replacements, and fitness solutions. There is increasing emphasis on personalized nutrition and holistic wellness.
Positioning
Medifast is positioned as a provider of comprehensive weight management solutions through its OPTAVIA program, differentiating itself with personalized coaching and community support.
Total Addressable Market (TAM)
The global weight management market is expected to reach hundreds of billions of dollars. Medifast is targeting a significant portion of this TAM through its OPTAVIA program and expanding its reach through new markets and product offerings.
Upturn SWOT Analysis
Strengths
- Strong Brand Recognition within its Target Market
- Direct-Selling Model (OPTAVIA) provides a Personalized Approach
- Established Infrastructure for Product Manufacturing and Distribution
- High Customer Loyalty
Weaknesses
- Reliance on Independent Health Coaches
- Potential Negative Perception of Meal Replacement Diets
- Vulnerability to Changes in Diet Trends
- High cost compared to other diets
Opportunities
- Expansion into New Geographic Markets
- Development of New Products and Services for Overall Health
- Increased Focus on Technology and Digital Solutions
- Partnerships with Healthcare Providers
Threats
- Intense Competition from Other Weight Management Companies
- Changes in Regulatory Environment
- Economic Downturn Affecting Consumer Spending
- Negative Publicity or Product Recalls
Competitors and Market Share
Key Competitors
- WW
- NUTX
- HLAL
Competitive Landscape
Medifast's competitive advantage lies in its direct-selling model, personalized coaching, and community support. However, it faces challenges from established players with broader market reach and lower-cost alternatives.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by the success of the OPTAVIA program and the expansion of its network of health coaches.
Future Projections: Future growth is projected to be driven by continued expansion into new markets, product innovation, and increased focus on technology and digital solutions. The extent to which the company achieves these initiatives will be based on future press releases and filings.
Recent Initiatives: Recent initiatives include the launch of new products, expansion into international markets, and investments in technology to enhance the OPTAVIA program.
Summary
Medifast's OPTAVIA program provides a distinct advantage in the weight management market. Its strengths include its direct-selling model, personalized coaching, and customer loyalty. Key challenges for the company includes competition, changes in diet trends and negative publicity. Medifast should seek to mitigate these challenges by maintaining strong quality control, diversifying offerings, and expanding the geographic reach of its OPTAVIA program.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q)
- Investor presentations
- Industry reports
- Market research reports
- Financial news articles
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions can change rapidly, and investors should conduct their own due diligence before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MEDIFAST INC
Exchange NYSE | Headquaters Baltimore, MD, United States | ||
IPO Launch date 1993-12-31 | Executive Chairman & CEO Mr. Daniel R. Chard | ||
Sector Consumer Cyclical | Industry Personal Services | Full time employees 504 | Website https://medifastinc.com |
Full time employees 504 | Website https://medifastinc.com | ||
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.